Meiragtx Holdings Plc(MGTX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

MGTX Meiragtx Holdings Plc

Market Closed 07-02 16:00:00 EDT

13.92

+1.12

+8.75%

盘后13.91

-0.01-0.07%

19:31 EDT

High13.94	Low12.78	Vol1.12M
Open12.95	D1 Closing12.80	Amplitude9.06%
Mkt Cap1.29B	Tradable Cap744.00M	Total Shares92.56M
T/O15.21M	T/O Rate2.10%	Tradable Shares53.45M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"MGTX","market":"US","secType":"STK","nameCN":"Meiragtx Holdings Plc","latestPrice":13.92,"timestamp":1783022400000,"preClose":12.8,"halted":0,"volume":1121142,"hourTrading":{"tag":"盘后","latestPrice":13.91,"preClose":13.92,"latestTime":"19:31 EDT","volume":11918,"amount":165791.5145,"timestamp":1783035061371,"change":-0.01,"changeRate":-0.000718,"amplitude":0.019993},"delay":0,"changeRate":0.08749999999999994,"floatShares":53448500,"shares":92557200,"eps":-1.48811,"marketStatus":"Market Closed","change":1.12,"latestTime":"07-02 16:00:00 EDT","open":12.95,"high":13.94,"low":12.78,"amount":15208402.223058,"amplitude":0.090625,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.48811,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1783324800000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1528430400000,"exchange":"NASDAQ","adjPreClose":12.8,"preHourTrading":{"tag":"盘前","latestPrice":12.8,"preClose":12.8,"latestTime":"08:49 EDT","volume":180,"amount":2305.43694,"timestamp":1782996577566,"change":0,"changeRate":0,"amplitude":0.08868},"postHourTrading":{"tag":"盘后","latestPrice":13.91,"preClose":13.92,"latestTime":"19:31 EDT","volume":11918,"amount":165791.5145,"timestamp":1783035061371,"change":-0.01,"changeRate":-0.000718,"amplitude":0.019993},"volumeRatio":0.5899326274065471,"impliedVol":0.9011,"impliedVolPercentile":0.4582},"requestUrl":"/m/hq/s/MGTX","defaultTab":"news","newsList":[{"id":"2645939015","title":"Does MeiraGTx (MGTX) Revenue Slide And Lower Institutional Ownership Reframe Its Long-Term Story?","url":"https://stock-news.laohu8.com/highlight/detail?id=2645939015","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645939015?lang=en_us&edition=fundamental","pubTime":"2026-06-22 02:18","pubTimestamp":1782065909,"startTime":"0","endTime":"0","summary":"In recent days, MeiraGTx Holdings reported a very large year-over-year drop in quarterly revenue alongside a double-digit decline in net profit, while key financial line items such as cash flow and operating profit remain undisclosed.\nAt the same time, institutional ownership fell quarter-over-quarter, with the largest institutional holder, Bill Nygren | OAKMX, sharply reducing its position, raising questions about shifting institutional confidence.\nNext, we’ll examine how this steep revenue...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-mgtx/meiragtx-holdings/news/does-meiragtx-mgtx-revenue-slide-and-lower-institutional-own","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-mgtx/meiragtx-holdings/news/does-meiragtx-mgtx-revenue-slide-and-lower-institutional-own","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["MGTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640516669","title":"MeiraGTx publishes corporate deck outlining late-stage gene therapy pipeline, manufacturing platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2640516669","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640516669?lang=en_us&edition=fundamental","pubTime":"2026-06-04 23:43","pubTimestamp":1780587819,"startTime":"0","endTime":"0","summary":"MeiraGTx highlighted four late-stage gene therapy programs, led by AAV-AQP1 in pivotal Phase 2 for radiation-induced xerostomia with potential BLA filing early 2027.X-linked retinitis pigmentosa program completed Phase 3, described as BLA and MAA ready, with process performance qualification reported complete.AAV-GAD for Parkinson’s disease positioned as Phase 3 ready, with a potential BLA filing in 2028, supported by sham-controlled trial data.Ophthalmology collaboration with Eli Lilly outlined, including USD 75 million upfront cash, up to USD 135 million near-term AAV-AIPL1 milestones, royalties.Hologen AI transaction detailed, including USD 200 million upfront cash, a JV backed by USD 230 million committed capital to fund AAV-GAD through commercialization.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only a","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260604:nNDL8gp686:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MGTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636896816","title":"MeiraGTx CEO Alexandria Forbes sells 62,000 shares for $568,540","url":"https://stock-news.laohu8.com/highlight/detail?id=2636896816","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636896816?lang=en_us&edition=fundamental","pubTime":"2026-05-20 09:05","pubTimestamp":1779239156,"startTime":"0","endTime":"0","summary":"MeiraGTx Holdings reported President and CEO Alexandria Forbes sold 62,000 ordinary shares on May 19, 2026.The shares were sold at a weighted average price of USD 9.17.Forbes held 1,387,695 ordinary shares following the transaction.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. MeiraGTx Holdings plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 19, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260520:nNDL9g6kHh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"MeiraGTx CEO Alexandria Forbes sells 62,000 shares for $568,540","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MGTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635150084","title":"Analysts Are Bullish on These Healthcare Stocks: Meiragtx Holdings (MGTX), CalciMedica (CALC)","url":"https://stock-news.laohu8.com/highlight/detail?id=2635150084","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635150084?lang=en_us&edition=fundamental","pubTime":"2026-05-15 20:10","pubTimestamp":1778847007,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Meiragtx Holdings (MGTX) and CalciMedica (CALC) with...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-meiragtx-holdings-mgtx-calcimedica-calc-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-meiragtx-holdings-mgtx-calcimedica-calc-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBI","MGTX","LU0128526141.USD","BK4139","BK4137","BK4112","LABU","LU0029874061.USD","BK4585","BLSG","BLSX","CALC","BK4581","BK4588","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635081692","title":"RBC Raises Price Target on MeiraGTx Holdings to $25 From $24, Keeps Outperform, Speculative Risk","url":"https://stock-news.laohu8.com/highlight/detail?id=2635081692","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635081692?lang=en_us&edition=fundamental","pubTime":"2026-05-15 19:59","pubTimestamp":1778846382,"startTime":"0","endTime":"0","summary":"MeiraGTx Holdings (MGTX) has an average rating of buy and mean price target of $28, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major bank","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MGTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635778870","title":"MeiraGTx files Form 3 for Chief Development Officer Penny Renee Fleck","url":"https://stock-news.laohu8.com/highlight/detail?id=2635778870","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635778870?lang=en_us&edition=fundamental","pubTime":"2026-05-15 09:01","pubTimestamp":1778806868,"startTime":"0","endTime":"0","summary":"MeiraGTx filed an initial Form 3 naming Penny Renee Fleck as chief development officer.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. MeiraGTx Holdings plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 14, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260515:nNDL1BFSR5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MGTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635250377","title":"MeiraGTx grants CDO Penny Fleck 100,000 options, 100,000 RSUs as inducement award","url":"https://stock-news.laohu8.com/highlight/detail?id=2635250377","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635250377?lang=en_us&edition=fundamental","pubTime":"2026-05-15 04:31","pubTimestamp":1778790662,"startTime":"0","endTime":"0","summary":"MeiraGTx granted Chief Development Officer Penny Fleck inducement equity awards tied to her start date.Package includes non-qualified stock options for 100,000 ordinary shares at exercise price USD 9.97, with 25% vesting on first anniversary then monthly vesting over 36 months.Grant also includes 100,000 time-based RSUs, with 50% vesting on second anniversary then 25% on each of third and fourth anniversaries.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260514:nNDL6BbcZ5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","BK4585","IE00B64PRP62.GBP","IE00B3QW5Z07.USD","SG9999014021.USD","IE00BN0W2W23.USD","MGTX","LU0314104364.USD","SG9999014013.SGD","BK4139","NDAQ","BK4588","SG9999014005.SGD","BK4112","IE00BKPKM429.USD","IE00BN0W2V16.EUR","SG9999014039.USD","IE00BN0W2T93.GBP","IE00BGHQF748.EUR","LU2095319765.USD","LU2210150020.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635257777","title":"MeiraGTx Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2635257777","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635257777?lang=en_us&edition=fundamental","pubTime":"2026-05-15 04:30","pubTimestamp":1778790600,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260514:nTUA59TZ8Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","MGTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635974173","title":"MeiraGTx reports Q1 EPS (57c), consensus (45c)","url":"https://stock-news.laohu8.com/highlight/detail?id=2635974173","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635974173?lang=en_us&edition=fundamental","pubTime":"2026-05-15 00:16","pubTimestamp":1778775411,"startTime":"0","endTime":"0","summary":"Reports Q1 revenue $293,000 vs. $1.93M last year. “Our achievements in the first few months of 2026 have materially strengthened MeiraGTx (MGTX) – ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/meiragtx-reports-q1-eps-57c-consensus-45c-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/meiragtx-reports-q1-eps-57c-consensus-45c-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","MGTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635498817","title":"MeiraGTx Holdings PLC reports results for the quarter ended March 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2635498817","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635498817?lang=en_us&edition=fundamental","pubTime":"2026-05-14 23:10","pubTimestamp":1778771417,"startTime":"0","endTime":"0","summary":"MeiraGTx Holdings PLC reports results for the quarter ended March 31 - Earnings SummaryMeiraGTx Holdings PLC MGTX.OQ reported a quarterly adjusted loss of 57 cents per share for the quarter ended Marc","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260514:nL8N41R1TJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MGTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635174237","title":"MeiraGTx Hldgs Q1 EPS $(0.57) Misses $(0.44) Estimate, Sales $293.000K Miss $13.913M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2635174237","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635174237?lang=en_us&edition=fundamental","pubTime":"2026-05-14 20:36","pubTimestamp":1778762212,"startTime":"0","endTime":"0","summary":"MeiraGTx Hldgs (NASDAQ:MGTX) reported quarterly losses of $(0.57) per share which missed the analyst consensus estimate of $(0.44) by 29.55 percent. This is a 11.76 percent decrease over losses of $(0.51) per share from","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/05/52557718/meiragtx-hldgs-q1-eps-0-57-misses-0-44-estimate-sales-293-000k-miss-13-913m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MGTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635717925","title":"MeiraGTx Q1 FY26 net loss widens to $46.31 million; revenue drops to $293,000","url":"https://stock-news.laohu8.com/highlight/detail?id=2635717925","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635717925?lang=en_us&edition=fundamental","pubTime":"2026-05-14 20:32","pubTimestamp":1778761979,"startTime":"0","endTime":"0","summary":"MeiraGTx posted a net loss of USD 46.31 million for quarter ended March 31, 2026, widening from USD 39.98 million a year earlier.Operating loss narrowed to USD 40.82 million from USD 41.6 million as total operating expenses edged down to USD 41.11 million from USD 43.52 million.Cash, cash equivalents, restricted cash totaled USD 73.8 million at March 31, 2026; management said funding runway extends into second half of 2028, including planned USD 25 million payment to reacquire bota-vec and scheduled Perceptive repayments of USD 25 million due June 2026 and USD 50 million due July 2027.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. MeiraGTx Holdings plc published the original content used to generate this news brief via EDGAR, the Elec","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260514:nNDLb4Zrnv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MGTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635717538","title":"MeiraGTx's Q1 Adjusted Loss Widens, Revenue Declines; Share Up Pre-Bell","url":"https://stock-news.laohu8.com/highlight/detail?id=2635717538","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635717538?lang=en_us&edition=fundamental","pubTime":"2026-05-14 20:27","pubTimestamp":1778761622,"startTime":"0","endTime":"0","summary":"MeiraGTx  reported a Q1 adjusted loss Thursday of $0.57 per diluted share, widening from a loss of $0.51 a year earlier.Analysts surveyed by FactSet expected a loss of $0.71.Revenue for the quarter ended March 31 was $293,000, down from $1.9 million a year earlier.Analysts polled by FactSet expected $17 million.Shares of MeiraGTx were up 2% in recent Thursday premarket activity.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","MGTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635712438","title":"Gene therapy firm MeiraGTx Q1 revenue drops, net loss widens","url":"https://stock-news.laohu8.com/highlight/detail?id=2635712438","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635712438?lang=en_us&edition=fundamental","pubTime":"2026-05-14 20:10","pubTimestamp":1778760607,"startTime":"0","endTime":"0","summary":"Gene therapy firm MeiraGTx Q1 revenue drops, net loss widensOverviewUK-U.S. gene therapy firm's Q1 revenue fell sharply, missing analyst expectationsCompany posted wider net loss for Q1MeiraGTx reacqu","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260514:nL1N41R0KX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MGTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635771294","title":"Earnings Flash (MGTX) MeiraGTx Posts Q1 Adjusted Net Loss $0.57 a Share, vs. FactSet Est of $0.75 Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2635771294","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635771294?lang=en_us&edition=fundamental","pubTime":"2026-05-14 20:07","pubTimestamp":1778760431,"startTime":"0","endTime":"0","summary":"Earnings Flash (MGTX) MeiraGTx Posts Q1 Adjusted Net Loss $0.57 a Share, vs. FactSet Est of $0.75 Loss","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MGTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635876712","title":"BRIEF-MeiraGTx Q1 Revenue USD 293 Thousand Vs. IBES Estimate USD 19.9 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2635876712","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635876712?lang=en_us&edition=fundamental","pubTime":"2026-05-14 20:00","pubTimestamp":1778760049,"startTime":"0","endTime":"0","summary":"BRIEF-MeiraGTx Q1 Revenue USD 293 Thousand Vs. IBES Estimate USD 19.9 Million\n\n\nMay 14 (Reuters) - MeiraGTx Q1 income from operations USD -40.817 million.\n\nQ1 net income USD -46.313 million\nQ1 operating expenses USD 41.11 million","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260514:nPLX4E878B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MGTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635712836","title":"MeiraGTx Q1 Revenue USD 293 Thousand VS. Ibes Estimate USD 19.9 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2635712836","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635712836?lang=en_us&edition=fundamental","pubTime":"2026-05-14 20:00","pubTimestamp":1778760004,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260514:nPLX4E878B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MGTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635123017","title":"Press Release: MeiraGTx Reports First Quarter 2026 Financial and Operational Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2635123017","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635123017?lang=en_us&edition=fundamental","pubTime":"2026-05-14 20:00","pubTimestamp":1778760000,"startTime":"0","endTime":"0","summary":"-- Received FDA Breakthrough Therapy Designation for AAV2-hAQP1. -- Reported positive three-year data from the Phase 1 AQUAx study of. AAV2-hAQP1 for the treatment of grade 2/3 late radiation-induced. \"To that end, I am extremely pleased to announce that Penny Fleck has joined MeiraGTx as Chief Development Officer,\" said Dr. Forbes. \"Penny brings tremendous experience from her 20+ years at J&J and Takeda leading development of many assets, including multiple global regulatory approvals. Importantly, while at J&J as Global Head of Specialty Ophthalmology, Penny worked closely with MeiraGTx on the development of bota-vec, from the licensing of the drug by J&J through Phase 3. Her extensive experience and broad expertise across drug development will help us achieve the potential approvals of bota-vec and AAV2-hAQP1, as well as progress our early stage programs such as Ribo-Lept","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MGTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632623147","title":"Miami International, Nathan's Famous, and 3 More Stocks See Action From Activist Investors -- Barrons.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2632623147","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632623147?lang=en_us&edition=fundamental","pubTime":"2026-05-02 06:18","pubTimestamp":1777673880,"startTime":"0","endTime":"0","summary":"These disclosures are from 13Ds filed with the Securities and Exchange Commission. 13Ds are filed within 10 days of an entity's attaining more than 5% in any class of a company's securities. Subsequent changes in holdings or intentions must be reported in amended filings. This material is from April 23 through April 29, 2026. Source: VerityData. Following the latest activity, Horizon Kinetics continues to own a 12.2% stake in Miami International Holdings' outstanding stock. Shares of Miami International Holdings have gained roughly 9.1% in value in 2026.Nathan's Famous Gamco Investors lowered its stake in the fast-food franchiser and licenser to 481,086 shares. Gamco Investors did so through the sale of 39,000 Nathan's Famous shares from Feb. 27 through April 22 at per share prices ranging from $100.53 to","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4112","BK4209","FRST","ISBC","MIAX","NATH","BK4139","BK4214","MNRO","BK4211","MGTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629849023","title":"MeiraGTx completes initial closing of strategic collaboration with Hologen Limited","url":"https://stock-news.laohu8.com/highlight/detail?id=2629849023","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629849023?lang=en_us&edition=fundamental","pubTime":"2026-04-24 20:36","pubTimestamp":1777034171,"startTime":"0","endTime":"0","summary":"Collaboration covers research, development, manufacturing, and commercialization of MeiraGTx gene therapies for Parkinson’s disease and genetic obesity disorders.Partnership also includes development of proprietary delivery device for local administration of gene therapy to central nervous system.Hologen previously paid USD 105 million toward USD 200 million upfront payment under March 2025 framework agreements.Structure sets Hologen to own 70% of Hologen Neuro AI following completion, with MeiraGTx Neuro UK holding 30%.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. MeiraGTx Holdings plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260424:nNDL3qvMYW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MGTX"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.meiragtx.com","stockEarnings":[{"period":"1week","weight":0.2073},{"period":"1month","weight":0.5065},{"period":"3month","weight":0.5163},{"period":"6month","weight":0.7823},{"period":"1year","weight":1.0116},{"period":"ytd","weight":0.7509}],"compareEarnings":[{"period":"1week","weight":0.0143},{"period":"1month","weight":-0.0195},{"period":"3month","weight":0.1356},{"period":"6month","weight":0.0902},{"period":"1year","weight":0.2004},{"period":"ytd","weight":0.0922}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited retinal diseases and large degenerative ocular diseases, neurodegenerative diseases, and xerostomia. Its programs in clinical development include Phase I/II clinical stage programs in achromatopsia, X-linked retinitis pigmentosa, and RPE65-deficiency; Phase I clinical trials for radiation-induced xerostomia; and Parkinson's program that has completed a Phase II trial. It has a research collaboration agreement with Janssen Pharmaceuticals, Inc. for the research, development, and commercialization of gene therapies for the treatment of inherited retinal disease. The company was incorporated in 2015 and is based in New York, New York.","yearOnYearQuotes":[{"month":1,"riseRate":0.375,"avgChangeRate":-0.012037},{"month":2,"riseRate":0.5,"avgChangeRate":0.0333},{"month":3,"riseRate":0.25,"avgChangeRate":-0.052743},{"month":4,"riseRate":0.75,"avgChangeRate":-0.013966},{"month":5,"riseRate":0.625,"avgChangeRate":0.013491},{"month":6,"riseRate":0.5,"avgChangeRate":0.058638},{"month":7,"riseRate":0.666667,"avgChangeRate":0.026087},{"month":8,"riseRate":0.375,"avgChangeRate":-0.045501},{"month":9,"riseRate":0.75,"avgChangeRate":-0.003363},{"month":10,"riseRate":0.375,"avgChangeRate":0.087707},{"month":11,"riseRate":0.625,"avgChangeRate":0.051284},{"month":12,"riseRate":0.625,"avgChangeRate":0.053515}],"exchange":"NASDAQ","name":"Meiragtx Holdings Plc","nameEN":"Meiragtx Holdings Plc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Meiragtx Holdings Plc(MGTX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Meiragtx Holdings Plc(MGTX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Meiragtx Holdings Plc,MGTX,Meiragtx Holdings Plc股票,Meiragtx Holdings Plc股票老虎,Meiragtx Holdings Plc股票老虎国际,Meiragtx Holdings Plc行情,Meiragtx Holdings Plc股票行情,Meiragtx Holdings Plc股价,Meiragtx Holdings Plc股市,Meiragtx Holdings Plc股票价格,Meiragtx Holdings Plc股票交易,Meiragtx Holdings Plc股票购买,Meiragtx Holdings Plc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Meiragtx Holdings Plc(MGTX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Meiragtx Holdings Plc(MGTX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}